WithdrawnNot applicableNCT01537354

Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome

Studying Infant acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Michigan
Principal Investigator
Steven Donn, M.D.
University of Michigan C & W Mott Children's Hospital
Intervention
Curosurf®(drug)
Eligibility
All sexes
Timeline
2012

Study locations (1)

Collaborators

Cornerstone Pharmaceuticals

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01537354 on ClinicalTrials.gov

Other trials for Infant acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Infant acute respiratory distress syndrome

← Back to all trials